Find comprehensive information on pancreatic cancer diagnosis history, including clinical documentation, medical coding (ICD-10 C25), symptoms, staging (TNM), risk factors, and treatment options. Learn about CA 19-9 tumor marker, diagnostic imaging (CT, MRI, endoscopic ultrasound), biopsy procedures, and pathology reports. This resource helps healthcare professionals, coders, and patients understand the importance of accurate pancreatic cancer diagnosis documentation for optimal patient care and research.
Also known as
Personal history of malignant neoplasm of pancreas
Indicates a past diagnosis of pancreatic cancer.
Malignant neoplasm of pancreas, unspecified
Used for pancreatic cancer when no further details are available.
Malignant neoplasms of pancreas, specified sites
Covers cancers of specific parts of the pancreas (head, body, tail).
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the pancreatic cancer currently active?
When to use each related code
| Description |
|---|
| Pancreatic Cancer |
| Pancreatic Cyst |
| Pancreatitis |
Using Z85.89 (Personal history of malignant neoplasm, other) instead of the more specific Z85.120 (Personal history of malignant neoplasm of pancreas) if documentation supports it, leading to underreporting.
Incorrectly coding active pancreatic cancer (C25.-) when the documentation clearly indicates a history of cancer, leading to overreporting and potential patient safety issues.
Failing to document laterality when applicable (e.g., head, body, tail) for a history of pancreatic cancer, potentially impacting data analysis and research.
Patient presents with a history of pancreatic cancer, diagnosed on [Date of Diagnosis]. The primary tumor site was [Location of Primary Tumor, e.g., head, body, tail] of the pancreas. Original staging was [Stage, e.g., I, II, III, IV] based on the [Staging System Used, e.g., AJCC 8th edition]. Histological subtype was [Histological Subtype, e.g., adenocarcinoma, adenosquamous carcinoma, neuroendocrine tumor]. Initial treatment included [Treatment Modalities, e.g., Whipple procedure, distal pancreatectomy, chemotherapy regimen, radiation therapy]. Current disease status is [Current Disease Status, e.g., no evidence of disease, recurrent, metastatic] with [Specific sites of recurrence or metastasis if applicable]. Patient reports [Symptoms, e.g., abdominal pain, jaundice, weight loss, fatigue]. Physical examination reveals [Relevant findings, e.g., palpable mass, ascites, lymphadenopathy]. Laboratory results show [Key lab values, e.g., elevated CA 19-9, liver function tests, complete blood count]. Imaging studies, including [Imaging Modalities used, e.g., CT scan, MRI, PET scan], demonstrate [Imaging findings, e.g., stable disease, progressive disease, response to treatment]. Assessment includes pancreatic cancer, history of [Specify if relevant, e.g., chemotherapy induced neuropathy, post-surgical complications]. Plan includes [Ongoing treatment plan, e.g., surveillance, chemotherapy, radiation, pain management, palliative care, referral to oncology, gastroenterology, surgery]. Patient education provided regarding disease management, potential complications, and follow-up care. Return appointment scheduled for [Date of next appointment].